Multimodal ctDNA profiling for cancer detection and monitoring in pan-cancer patients with advanced disease enrolled in the SHIVA02 trial
Kenza Nedara, Marine Gorse, Julien Masliah‐Planchon, Klaus von Grafenstein et autres
0 citationsmedRxiv
Célia Dupain
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
73Publications signalées
805Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersCancer Diagnosis and TreatmentCervical Cancer and HPV ResearchHead and Neck Cancer Studies
Publications récentes
Corrigendum to “Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis” The Lancet Regional Health – Europe, Volume 60, January 2026, 101524
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, Zoé Nevière et autres
0 citationsThe Lancet Regional Health - Europe
Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials
Paul Matte, Nael Alshatti, Matthieu Roulleaux-Dugage, Jean‐Eudes Fahrner et autres
0 citationsEuropean Journal of Cancer
Integrative genomic and transcriptomic profiles from a prospective cervical cancer study
Solenn Barraud, Lolita Lecompte, Rebecca Loison, Stacy Cyrille et autres
0 citationsnpj Precision Oncology
Rôle de la Réunion de concertation pluridisciplinaire nationale dans la prise en charge diagnostique et thérapeutique des patients atteints de cancers de primitif inconnu (CAPI)
Nicolas Jacquin, Zoe Nevière, Kenza Nedara, Célia Dupain et autres
0 citationsBulletin du Cancer
A clustering-stratified cross-validation framework for validating omics survival models: application to head and neck cancer
Antoine Dubray‐Vautrin, O. Choussy, Constance Lamy, Grégoire Marret et autres
5 citationsBMC Medical Research Methodology
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, Zoé Nevière et autres
2 citationsThe Lancet Regional Health - Europe
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, Dominika Foretek et autres
3 citationsNAR Cancer
3017P French national multidisciplinary tumor board improves the management and survival of patients with cancer of unknown primary
Sarah Watson, Célia Dupain, Nicolas Jacquin, Aurélien Latouche et autres
0 citationsAnnals of Oncology
250eP Clinical and biological characteristics of a French cohort of cancer of unknown primary with suspected breast origin
Sarah Watson, Sonja Aho, Kenza Nedara, Célia Dupain et autres
0 citationsAnnals of Oncology
134P Molecular biomarker analysis in the phase II basket PEVOSq trial testing pembrolizumab with vorinostat on late-stage squamous cell carcinoma supports HDAC inhibition as an immunotherapy enhancer
Célia Dupain, M. Francisco, Gianmaria Frigè, Bastien Cabarrou et autres
0 citationsAnnals of Oncology
698P Clinical, pathological and molecular characteristics of brain metastases from cancer of unknown primary (BM-CUP): A multicenter French retrospective cohort
André Bernardi, Kenza Nedara, Célia Dupain, Anne Mc Leer et autres
0 citationsAnnals of Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.